Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
Status:
Recruiting
Trial end date:
2022-05-27
Target enrollment:
Participant gender:
Summary
Patients who meet the enrollment criteria will be randomized 1:1 to either the lidocaine or
the placebo group.
In the lidocaine group, at the end of the induction of general anesthesia, a bolus injection
of lidocaine 1.5 mg/kg, calculated using the patient's ideal body weight and given as an
infusion over 10 minutes, followed by a continuous infusion of lidocaine at 1.5 mg/kg per
hour for the whole surgical procedure and will be discontinued at the end of surgery. In the
placebo group, the same volume of normal saline will be administered during anesthesia.